MV Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2
Closed -$204 1213
2025
Q4
$204 Hold
2
﹤0.01% 1028
2025
Q3
$110 Buy
+2
New +$100 ﹤0.01% 997
2025
Q2
Sell
-2
Closed -$87 1090
2025
Q1
$87 Sell
2
-69
-97% -$3.49K ﹤0.01% 996
2024
Q4
$3.99K Buy
71
+30
+73% +$1.87K ﹤0.01% 630
2024
Q3
$2.79K Buy
41
+39
+1,950% +$2.2K ﹤0.01% 673
2024
Q2
$85 Sell
2
-4
-67% -$220 ﹤0.01% 911
2024
Q1
$415 Buy
6
+3
+100% +$190 ﹤0.01% 713
2023
Q4
$222 Buy
+3
New +$197 ﹤0.01% 703
2021
Q3
Sell
-50
Closed -$6K 719
2021
Q2
$6K Buy
+50
New +$5.97K ﹤0.01% 460

Other funds holding EXAS

MV Capital Management's EXAS Position: Q1 2026 in Review

MV Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 2 shares — an estimated $204 sold.

MV Capital Management first reported a position in EXAS in Q2 2021 and held it in 9 quarters. The position peaked at $6K in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • MV Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • MV Capital Management sold 2 Exact Sciences shares in Q1 2026, an estimated $204.
  • MV Capital Management first reported a position in Exact Sciences in Q2 2021 and held it in 9 quarters.
  • MV Capital Management's Exact Sciences position peaked at $6K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on MV Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.